drugset / Trial / NCT01330030

Selegiline Patch for Treatment of Nicotine Dependence

NCT01330030

RandomizedFactorialQuadruple-blindTreatment

Summary

Relapse to smoking is a common problem affecting smokers who seek treatment. The purpose of this study is examine whether selegiline, given in the form of a skin patch, is effective in stopping smoking.

Timeline

Start
2005-07
Primary completion
2008-08
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Selegiline Unknown 6 mg Other

Indications